Literature DB >> 17383641

Critical function of Ikaros in controlling Aiolos gene expression.

Ata Ghadiri1, Marianne Duhamel, Aarne Fleischer, Andreas Reimann, Frederic Dessauge, Angelita Rebollo.   

Abstract

To characterize the regulation of lymphoid Aiolos transcription factor, we have cloned its promoter. Full promoter and nested deletions were expressed in lymphoid and non-lymphoid cell lines. The minimal promoter activity could be considered as a 172bp upstream from the ATG for Jurkat and HEK293 cells and as a 370bp fragment for U937 cells. Moreover, we have mapped the transcription initiation site. Retardation gels showed binding activity for Ikaros, NFkappaB and AP4 transcription factors and mutations in their binding sites abolish Aiolos promoter activity. Chromatin immunoprecipitation assay revealed that Ikaros, NFkappaB and AP4 are bound to Aiolos promoter. The important function of Ikaros and NFkappaB is underlined by their over expression, which results in the trans-activation of the promoter and drives Aiolos expression in cell lines and in freshly isolated B and T cells, while over expression of a dominant negative Ikaros isoform is able to block Aiolos expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383641     DOI: 10.1016/j.febslet.2007.03.025

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Variations in mRNA and protein levels of Ikaros family members in pediatric T cell acute lymphoblastic leukemia.

Authors:  Julie L Mitchell; Thomas M Yankee
Journal:  Ann Transl Med       Date:  2016-10

2.  Down-regulated expression of IKZF1 mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Wenlong Hu; Liangdan Sun; Jinping Gao; Yun Li; Peiguang Wang; Yilin Cheng; Tingmeng Pan; Jianwen Han; Yangsheng Liu; Wensheng Lu; Xianbo Zuo; Yujun Sheng; Sha Yao; Caifeng He; Zeying Yu; Xianyong Yin; Yong Cui; Sen Yang; Xuejun Zhang
Journal:  Rheumatol Int       Date:  2010-08-01       Impact factor: 2.631

3.  Immunogenetics of Lupus Erythematosus.

Authors:  Begüm Ünlü; Ümit Türsen; Navid Jabalameli; Fahimeh Abdollahimajd; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4.

Authors:  C C Bjorklund; L Lu; J Kang; P R Hagner; C G Havens; M Amatangelo; M Wang; Y Ren; S Couto; M Breider; Y Ning; A K Gandhi; T O Daniel; R Chopra; A Klippel; A G Thakurta
Journal:  Blood Cancer J       Date:  2015-10-02       Impact factor: 11.037

Review 5.  The Ikaros family of zinc-finger proteins.

Authors:  Yingzhi Fan; Duo Lu
Journal:  Acta Pharm Sin B       Date:  2016-06-24       Impact factor: 11.413

6.  Biochemical and cellular characterization of transcription factors binding to the hyperconserved core promoter-associated M4 motif.

Authors:  Ngo Tat Trung; Elisabeth Kremmer; Gerhard Mittler
Journal:  BMC Genomics       Date:  2016-08-30       Impact factor: 3.969

7.  Effect of Notch and PARP Pathways' Inhibition in Leukemic Cells.

Authors:  Luka Horvat; Mariastefania Antica; Maja Matulić
Journal:  Cells       Date:  2018-06-14       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.